In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MPM/Novartis Fund Deals with Radius

Executive Summary

In mid-September, the MPM Capital/Novartis investment fund closed a $10 million investment in Radius Health -- getting an option on Radius's Phase II osteoporosis candidate and the first evidence that its strategy of melding business development with VC can work. And that's why the outcome will be important to watch. If the Radius deal is followed by others, Big Pharma will try to copy the model. If the deal is seen as preventing Radius from getting a profitable exit for its investors, serving Novartis' needs at their expense, corporate VC will go back to the drawing board.
Advertisement

Related Content

Radius Raises $91 Million, Moves Toward Public Listing
Radius Takes $91MM To Support Osteoporosis Drug, Moves Toward Public Listing
Radius Takes $91MM To Support Osteoporosis Drug, Moves Toward Public Listing
Best of the Blog, START-UP July-August 2009
Building Bone: Next-Generation Osteoporosis Therapies
Financings Roundup: Optimer, Sopherion, Proteon, Pearl
Financings Roundup: Optimer, Sopherion, Proteon, Pearl
Deals Of The Week: Wyeth/Santaris, Novartis/HHS, Cephalon/Ception ...
Deals Of The Week: Wyeth/Santaris, Novartis/HHS, Cephalon/Ception ...
Novartis' Competing Venture Funds Pursue Lower-Cost Innovation

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV003008

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel